Choosing a continuous glucose monitor can feel overwhelming when you're staring down a list of specs and brand names you've never had to think about before. If you've narrowed things down to the Dexcom G7 and the FreeStyle Libre 3, you're already looking at two of the most widely used and well-regarded CGMs available today. This guide breaks down how they compare across accuracy, wear time, app features, and insurance coverage so you can go into the conversation with your healthcare provider feeling prepared.
Dexcom G7 vs. FreeStyle Libre 3: Side-by-Side
Before diving into the details, here's a quick snapshot of how these two devices stack up on the features most people ask about first. Keep in mind that individual experience varies, and your provider can help you weigh what matters most for your management goals.
| Feature | Dexcom G7 | FreeStyle Libre 3 |
|---|---|---|
| Sensor Wear Time | 10 days | 14 days |
| MARD (Accuracy Metric) | ~8.2% (arm placement) | ~9.2% |
| Warm-Up Time | 30 minutes | 60 minutes |
| Real-Time Alerts | Yes (customizable) | Yes (optional) |
| Continuous Transmission | Yes | Yes |
| Calibration Required | None | None |
| Receiver Option | Yes | No (smartphone only) |
| Insulin Pump Integration | Yes (Tandem t:slim X2, Omnipod 5) | Limited (iCGM status, expanding) |
| Data Sharing | Yes (Dexcom Clarity) | Yes (LibreView) |
| FDA-Cleared for Treatment Decisions | Yes | Yes |
| Approved Insertion Sites | Upper arm, abdomen, upper buttock (ages 2-6) | Back of upper arm only |
MARD (Mean Absolute Relative Difference) measures how closely CGM readings align with blood glucose values. A lower percentage reflects closer agreement. Values shown are manufacturer-published figures; results in independent studies may vary.
Accuracy, Wear Time, and What the Research Shows
Accuracy is usually the first thing people want to know about when comparing CGMs, and it's worth understanding how that accuracy is measured. The standard metric is called MARD (Mean Absolute Relative Difference). The lower the number, the closer the sensor's readings tend to be to actual blood glucose values. Both devices carry single-digit MARD scores, which puts them in the range considered clinically reliable for treatment decisions.
The manufacturer-published MARD for the Dexcom G7 is approximately 8.2% for arm placement, based on a clinical study of 316 adults published in PubMed Central. The FreeStyle Libre 3 Plus (the version of the Libre 3 sensor currently available through Adapt Health Diabetes) carries a manufacturer-published MARD of approximately 8.2% as well, while the standard Libre 3 is published at approximately 9.2%. A head-to-head study published in PubMed Central found the FreeStyle Libre 3 outperforming the G7 in certain conditions, while Dexcom's own data shows advantages during rapid glucose changes. The honest takeaway is that both devices perform well, and real-world experience varies from person to person.
On wear time, the Libre 3's 14-day sensor life has a clear practical advantage over the G7's 10-day wear period. Fewer sensor changes mean less interruption to your routine. That said, the G7 has a notably shorter warm-up time (30 minutes versus 60 minutes for the Libre 3), which matters if you're switching sensors before a meal or an active part of your day.
One other practical difference worth knowing: the G7 is approved for multiple insertion sites (upper arm, abdomen, and upper buttock for younger children), while the Libre 3 is FDA-cleared for the back of the upper arm only. More approved sites give G7 users more flexibility to rotate placements and avoid scar tissue buildup over time.
App Experience, Alerts, and Insulin Pump Compatibility
Beyond how a CGM measures glucose, how you interact with the data every day matters just as much. Both devices offer companion apps with real-time trend views and data sharing, but they take fairly different approaches.
The Dexcom G7 app is built around real-time alerts and customization. You can set personalized thresholds for high and low glucose, adjust how aggressively the system alerts you, and share live data with up to 10 followers through Dexcom Clarity. The G7 also works with the Dexcom G7 receiver for users who prefer not to rely on a smartphone, and it integrates directly with insulin pumps including the Tandem t:slim X2 with Control-IQ and the Omnipod 5 for automated insulin delivery.
The FreeStyle Libre 3 app is designed with simplicity in mind. It displays current glucose, trend arrows, and a clean graph view without a lot of extra setup. Alerts are available but optional, which some users appreciate and others find limiting. Data uploads to LibreView for review by your care team, and the app syncs with Apple Health. One thing to know: the Libre 3 is a smartphone-only system. There is no standalone receiver, and watch app support is not currently available. The FreeStyle Libre 3 reader is compatible with the Libre 2 series; if you're using the Libre 3 specifically, you'll want to confirm compatibility with your device before ordering.
For users who rely on an insulin pump or want tight integration between their CGM and delivery system, the Dexcom G7 currently has a clear advantage. For those who prioritize a low-fuss daily experience without a lot of app management, the Libre 3 is a genuinely excellent option. Visit our Dexcom and Abbott FreeStyle pages to explore the full range of sensors and accessories available through Adapt Health Diabetes.
Why the Right CGM Choice Makes a Real Difference
The best CGM is the one you'll actually use consistently, and that means finding a device that fits how you live, not just how it performs on a spec sheet. A CGM you trust gives you the confidence to act on your data, and consistent use has been shown to support better time in range, lower A1C, and fewer dangerous low episodes. Whether you're newly diagnosed or have been managing diabetes for years, having a device that works with your routine rather than against it can take a meaningful amount of stress out of your day.
At Adapt Health Diabetes, we make it easy to get the CGM supplies you need through your insurance, with support if you have questions along the way. Explore our Learning Center for more guides on choosing and using diabetes devices.
Frequently Asked Questions About Dexcom G7 and FreeStyle Libre 3
Is one CGM more accurate than the other?
Both devices carry single-digit MARD scores and are FDA-cleared for treatment decisions, meaning both are considered clinically reliable. Manufacturer data puts the Dexcom G7 at approximately 8.2% MARD (arm placement) and the FreeStyle Libre 3 at approximately 9.2%, though a head-to-head study in PubMed Central found the Libre 3 outperforming the G7 in certain controlled conditions. The practical difference for most people is small, and individual results vary. Your provider can help you weigh accuracy data in the context of your specific management needs.
Can I make insulin dosing decisions based on readings from either device?
Yes. Both the Dexcom G7 and FreeStyle Libre 3 are FDA-cleared for treatment decisions, including insulin dosing, without routine confirmatory fingersticks in most circumstances. A fingerstick may still be recommended if your symptoms don't match your CGM reading, particularly during rapid glucose changes. Always follow your healthcare provider's guidance on when confirmation is appropriate.
Do both devices work with insulin pumps?
The Dexcom G7 currently has broader pump integration, working directly with the Tandem t:slim X2 with Control-IQ and the Omnipod 5 for automated insulin delivery. The FreeStyle Libre 3 holds iCGM status, which qualifies it for future pump integration, but compatibility is more limited at this time. If pump integration is a priority for you, the G7 is the stronger option right now.
How does alert customization compare between the two?
The Dexcom G7 offers robust, customizable alerts for high and low glucose levels, including predictive urgent low alerts. Alerts can be fine-tuned to your target thresholds and notification preferences. The FreeStyle Libre 3 does offer alerts, but the customization options are more limited. For users who rely on real-time alarms for overnight safety or variable glucose patterns, the G7's alert system is generally considered the stronger tool.
Does insurance cover both Dexcom and FreeStyle Libre products?
Many private insurance plans, Medicare, and Medicaid cover both systems for people who meet eligibility requirements, which typically include a diabetes diagnosis, insulin use, and a valid prescription from a healthcare provider. Coverage specifics vary by plan, and prior authorization may be required. If you have questions about your coverage, our team is happy to help you work through it.
Get Your CGM Supplies Delivered Through Your Insurance
Whether you've already chosen your device or you're still deciding, Adapt Health Diabetes makes ordering CGM sensors, transmitters, and accessories straightforward. Browse our full selection of Dexcom products and Abbott FreeStyle products, or visit our Resources page for additional support.
Questions about which device is covered under your plan? Contact our team and we'll walk you through it.
This article is for educational purposes only and does not replace professional medical advice. Always consult your healthcare provider regarding device selection and diabetes management decisions.
Sources
- Freckmann G, et al. Comparison of Point Accuracy Between Two Widely Used Continuous Glucose Monitoring Systems. PubMed Central. 2024.
- Bhargava A, et al. Accuracy and Safety of Dexcom G7 Continuous Glucose Monitoring in Adults with Diabetes. PubMed Central. 2022.
- American Association of Diabetes Care and Education Specialists. Dexcom G7 and Libre 3 Comparison. danatech by ADCES.
